Point72 Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Point72 Asset Management's VRTX Position: Q2 2026 in Review
Point72 Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 2,625 shares worth $1.3M. The stake represents ﹤0.01% of the portfolio and ranks #2667 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in VRTX as recently as Q3 2023.
Point72 Asset Management first reported a position in VRTX in Q2 2014 and has held it in 30 quarters since. The position peaked at $143M in Q1 2021. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Point72 Asset Management held 2,625 shares of Vertex Pharmaceuticals worth $1.3M as of Q2 2026.
- Vertex Pharmaceuticals was a new Point72 Asset Management position in Q2 2026.
- Vertex Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q2 2026, its #2667 holding.
- Point72 Asset Management first reported a position in Vertex Pharmaceuticals in Q2 2014 and has held it in 30 quarters since.
- Point72 Asset Management's Vertex Pharmaceuticals position peaked at $143M in Q1 2021.
- 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.